Search research articles
Contact Us
Filters
Showing results (21-30 of 225) with videos related to
Page
of 23
Sort By:
Clinical Lung Cancer
|
October 1, 2008
Will FLEX allow us flexibility in the therapy of advanced non-small-cell lung cancer? Insights from the 2008 American Society of Clinical Oncology Meeting
Corey J Langer
Clinical Lung Cancer
|
April 23, 2005
Role of zoledronic acid in the setting of bone metastases from non-small-cell lung cancer
Corey J Langer
Clinical Lung Cancer
|
June 13, 2006
Neglected and underrepresented subpopulations: elderly and performance status 2 patients with advanced-stage non-small-cell lung cancer
Corey J Langer
Cancer
|
January 28, 2012
Exploring biomarkers in head and neck cancer
Corey J Langer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 28, 2013
Epidermal growth factor receptor inhibition in mutation-positive non-small-cell lung cancer: is afatinib better or simply newer?
Corey J Langer
Clinical Lung Cancer
|
January 24, 2007
Successful coronary artery bypass grafting after concurrent chemoradiation therapy in a patient with non-small-cell lung cancer: case report and review of the literature
Sulfi Ibrahim, Corey J Langer
Current Opinion in Oncology
|
February 9, 2012
Older age, poor performance status and major comorbidities: how to treat high-risk patients with advanced nonsmall cell lung cancer
Charu Aggarwal, Corey J Langer
Current Problems in Cancer
|
May 29, 2012
Introduction. “small steps” in our battle with SCLC
Benjamin Movsas, Corey J Langer
Cancer
|
January 17, 2020
Systemic therapy for elderly patients with non-small cell lung cancer: Where do we stand in 2019?
Charu Aggarwal, Corey J Langer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2005
Current management of brain metastases, with a focus on systemic options
Corey J Langer, Minesh P Mehta
Page
of 23
Search research articles
Search
Showing results (21-30 of 225) with videos related to
Sort By:
Page
of 23
Clinical Lung Cancer
|
October 1, 2008
Will FLEX allow us flexibility in the therapy of advanced non-small-cell lung cancer? Insights from the 2008 American Society of Clinical Oncology Meeting
Corey J Langer
Clinical Lung Cancer
|
April 23, 2005
Role of zoledronic acid in the setting of bone metastases from non-small-cell lung cancer
Corey J Langer
Clinical Lung Cancer
|
June 13, 2006
Neglected and underrepresented subpopulations: elderly and performance status 2 patients with advanced-stage non-small-cell lung cancer
Corey J Langer
Cancer
|
January 28, 2012
Exploring biomarkers in head and neck cancer
Corey J Langer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 28, 2013
Epidermal growth factor receptor inhibition in mutation-positive non-small-cell lung cancer: is afatinib better or simply newer?
Corey J Langer
Clinical Lung Cancer
|
January 24, 2007
Successful coronary artery bypass grafting after concurrent chemoradiation therapy in a patient with non-small-cell lung cancer: case report and review of the literature
Sulfi Ibrahim, Corey J Langer
Current Opinion in Oncology
|
February 9, 2012
Older age, poor performance status and major comorbidities: how to treat high-risk patients with advanced nonsmall cell lung cancer
Charu Aggarwal, Corey J Langer
Current Problems in Cancer
|
May 29, 2012
Introduction. “small steps” in our battle with SCLC
Benjamin Movsas, Corey J Langer
Cancer
|
January 17, 2020
Systemic therapy for elderly patients with non-small cell lung cancer: Where do we stand in 2019?
Charu Aggarwal, Corey J Langer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2005
Current management of brain metastases, with a focus on systemic options
Corey J Langer, Minesh P Mehta
Page
of 23